| Sep 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | |
|---|---|---|---|---|---|---|---|
| Total Revenues ($Mil): | 59.60 | 60.30 | 56.85 | 61.60 | 62.49 | 50.62 | 50.42 |
| Depreciation & Amort ($Mil): | 4.66 | 4.66 | 5.10 | 5.82 | 5.86 | 5.90 | 9.14 |
| Operating Income ($Mil): | -4.48 | -2.37 | -9.82 | -6.63 | -3.49 | -11.18 | -39.89 |
| Net Income ($Mil): | -4.78 | -2.96 | -11.27 | -9.43 | -8.81 | -80.09 | -80.09 |
| Earnings Per Share ($): | -0.16 | -0.10 | -0.45 | -0.39 | -0.46 | -2.15 | -7.40 |
| Dividends ($): | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | N/C | N/C |
| Sep 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | |
|---|---|---|---|---|---|---|---|
| Current Assets ($Mil): | 30.71 | 34.02 | 38.80 | 37.41 | 47.49 | 29.21 | 35.28 |
| Current Liabilities ($Mil): | 8.20 | 8.57 | 8.83 | 14.29 | 14.44 | 21.59 | 27.73 |
| Long Term Debt ($Mil): | 0.00 | 0.33 | 0.00 | 0.00 | 0.00 | 0.41 | 2.29 |
| Shares Outstanding (000): | 29970 | 29920 | 29250 | 24540 | 22380 | 15040 | 11150 |
| Common Equity ($Mil): | 46.85 | 52.43 | 50.90 | 45.47 | 58.25 | 35.04 | 38.69 |
| Sep 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | |
|---|---|---|---|---|---|---|---|
| Profit Margin (%): | -8.02 | -4.91 | -19.82 | -15.31 | -14.10 | -46.54 | -158.85 |
| Return on Equity (%): | -9.61 | -5.65 | -22.14 | -20.74 | -15.12 | -67.24 | -207.00 |
| Return on Assets (%): | -8 | -4.76 | -18.52 | -15.29 | -11.65 | -39.65 | -113.72 |
| P/E Ratio: | 0 | -51.10 | -9.02 | -25.00 | -18.00 | -2.33 | 0.00 |
| Price/Book: | 1 | 2.92 | 2.33 | 5.26 | 3.18 | 2.15 | 0.00 |
| Debt Equity: | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.01 | 0.06 |
| Interest Coverage: | 0.00 | -293.00 | 0.00 | -112.63 | -48.29 | -25.98 | -122.57 |
| Book Value ($): | 1.56 | 1.75 | 1.74 | 1.85 | 2.60 | 2.33 | 3.47 |
| Price/Sales: | 1.68 | 0.44 | 2.09 | 3.88 | 2.97 | 1.49 | 0.00 |
| Dividend Payout (%): | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |

| AMGEN | +5.10 | 55.47 | |
| GILEAD SCIENCES | -8.10 | 44.45 | |
| CELGENE CP | -16.20 | 55.97 | |
| BIOGEN IDEC INC | -30.20 | 44.26 | |
| GENENTECH INC | +4.70 | 80.36 |
